Pretraživanje
Prikaz rezultata 1-1 od 1
PCR43 A Review of Migraine-Related Pros in FDA Labelling Claims (2018-2023)
(Elsevier, 2023)
Objective
The objective of this review was to characterize the inclusion of migraine patient-reported outcomes (PROs) in FDA approvals subsequent the FDA’s release in 2018 of the Patient Focused Drug Development (PFDD) ...